Valeant Pharmaceuticals International has completed the acquisition of Salix Pharmaceuticals.
Salix Pharmaceuticals focuses on the gastroenterology market. The company offers treatments such as XIFAXAN, RUCONEST, APRISO, UCERIS and RELISTOR.
Valeant completes Salix Pharmaceuticals acquisition
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.